You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

ZINC SULFATE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for zinc sulfate and what is the scope of patent protection?

Zinc sulfate is the generic ingredient in one branded drug marketed by Abraxis Pharm, Am Regent, Apotex, Fresenius Kabi Usa, Gland Pharma Ltd, Nivagen Pharms Inc, Somerset Theraps Llc, and Zydus Pharms, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for zinc sulfate. Nine suppliers are listed for this compound.

Drug Sales Revenue Trends for ZINC SULFATE

See drug sales revenues for ZINC SULFATE

Recent Clinical Trials for ZINC SULFATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
UNC Lineberger Comprehensive Cancer CenterPhase 1/Phase 2
University Cancer Research Fund at Lineberger Comprehensive Cancer CenterPhase 1/Phase 2
Bellicum PharmaceuticalsPhase 1/Phase 2

See all ZINC SULFATE clinical trials

Pharmacology for ZINC SULFATE
Medical Subject Heading (MeSH) Categories for ZINC SULFATE

US Patents and Regulatory Information for ZINC SULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Gland Pharma Ltd ZINC SULFATE zinc sulfate SOLUTION;INTRAVENOUS 216249-002 May 3, 2022 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Zydus Pharms ZINC SULFATE zinc sulfate SOLUTION;INTRAVENOUS 217074-003 Aug 22, 2023 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Zydus Pharms ZINC SULFATE zinc sulfate SOLUTION;INTRAVENOUS 217074-001 Aug 22, 2023 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Am Regent ZINC SULFATE zinc sulfate SOLUTION;INTRAVENOUS 209377-001 Jul 18, 2019 AP RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Somerset Theraps Llc ZINC SULFATE zinc sulfate SOLUTION;INTRAVENOUS 216135-002 Jul 17, 2024 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.